Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tumor Lysis Syndrome × AZD0466 × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Tumor Lysis Syndrome 1 Recurrence 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hematologic Neoplasms 1

Interventions

rasburicase 6 Allopurinol 3 Urate Oxidase 2 venetoclax 1 obinutuzumab 1 alvocidib 1 Lenalidomide 1 Febuxostat 1 Bendamustine Hydrochloride 1 AZD0466 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04214093 2023-08-02

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

AstraZeneca

Phase 1 Terminated

LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Recurrence, Tumor Lysis Syndrome, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡